Prashant Nagre sold 44,000 shares of Fermenta Biotech Limited for ₹2.20 Cr at ₹499.87 apiece, reducing his stake from 0.47% to 0.32% via a market sale.
A pharmaceutical manufacturer established in 1951, Fermenta Biotech produces active pharmaceutical ingredients, aquaculture chlorine products, biotechnology formulations, and nutraceutical supplements for healthcare applications. The company operates across multiple segments within the pharmaceutical and healthcare sectors, serving both domestic and international markets with a diversified product range. Its portfolio spans traditional pharmaceuticals to specialized biotechnology solutions and wellness products.
